BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 19967722)

  • 1. Oncogenic NRF2 mutations in squamous cell carcinomas of oesophagus and skin.
    Kim YR; Oh JE; Kim MS; Kang MR; Park SW; Han JY; Eom HS; Yoo NJ; Lee SH
    J Pathol; 2010 Mar; 220(4):446-51. PubMed ID: 19967722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations of the INK4a locus in squamous cell carcinomas of human skin.
    Kubo Y; Urano Y; Matsumoto K; Ahsan K; Arase S
    Biochem Biophys Res Commun; 1997 Mar; 232(1):38-41. PubMed ID: 9125147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global downstream pathway analysis reveals a dependence of oncogenic NF-E2-related factor 2 mutation on the mTOR growth signaling pathway.
    Shibata T; Saito S; Kokubu A; Suzuki T; Yamamoto M; Hirohashi S
    Cancer Res; 2010 Nov; 70(22):9095-105. PubMed ID: 21062981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 mutations in human aggressive and nonaggressive basal and squamous cell carcinomas.
    Bolshakov S; Walker CM; Strom SS; Selvan MS; Clayman GL; El-Naggar A; Lippman SM; Kripke ML; Ananthaswamy HN
    Clin Cancer Res; 2003 Jan; 9(1):228-34. PubMed ID: 12538474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer.
    Hayes JD; McMahon M
    Trends Biochem Sci; 2009 Apr; 34(4):176-88. PubMed ID: 19321346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ERBB2 kinase domain mutation in the lung squamous cell carcinoma.
    Lee JW; Soung YH; Kim SY; Nam SW; Park WS; Wang YP; Jo KH; Moon SW; Song SY; Lee JY; Yoo NJ; Lee SH
    Cancer Lett; 2006 Jun; 237(1):89-94. PubMed ID: 16029927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High frequency of p53 mutations in human oral epithelial dysplasia and primary squamous cell carcinoma detected by yeast functional assay.
    Kashiwazaki H; Tonoki H; Tada M; Chiba I; Shindoh M; Totsuka Y; Iggo R; Moriuchi T
    Oncogene; 1997 Nov; 15(22):2667-74. PubMed ID: 9400993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract.
    Chung KY; Mukhopadhyay T; Kim J; Casson A; Ro JY; Goepfert H; Hong WK; Roth JA
    Cancer Res; 1993 Apr; 53(7):1676-83. PubMed ID: 8453641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational spectrum of p53 gene in arsenic-related skin cancers from the blackfoot disease endemic area of Taiwan.
    Hsu CH; Yang SA; Wang JY; Yu HS; Lin SR
    Br J Cancer; 1999 Jun; 80(7):1080-6. PubMed ID: 10362120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced transcription of the RB2/p130 gene in human lung cancer.
    Xue Jun H; Gemma A; Hosoya Y; Matsuda K; Nara M; Hosomi Y; Okano T; Kurimoto F; Seike M; Takenaka K; Yoshimura A; Toyota M; Kudoh S
    Mol Carcinog; 2003 Nov; 38(3):124-9. PubMed ID: 14587097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational analyses of candidate genes in human squamous cell carcinomas.
    Petroianu A; Boson WL; Bale AE; Friedman E; De Marco L
    Laryngoscope; 1999 Apr; 109(4):661-3. PubMed ID: 10201760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P53 expression, p53 and Ha-ras mutation and telomerase activation during nitrosamine-mediated hamster pouch carcinogenesis.
    Chang KW; Sarraj S; Lin SC; Tsai PI; Solt D
    Carcinogenesis; 2000 Jul; 21(7):1441-51. PubMed ID: 10874024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple high-grade bronchial dysplasia and squamous cell carcinoma: concordant and discordant mutations.
    Boyle JO; Lonardo F; Chang JH; Klimstra D; Rusch V; Dmitrovsky E
    Clin Cancer Res; 2001 Feb; 7(2):259-66. PubMed ID: 11234877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infrequent mutation of the human envoplakin gene is closely linked to the tylosis oesophageal cancer locus in sporadic oesophageal squamous cell carcinomas.
    Iwaya T; Maesawa C; Kimura T; Ogasawara S; Ikeda K; Kimura Y; Noda Y; Ishida K; Sato N; Saito K; Masuda T
    Oncol Rep; 2005 Apr; 13(4):703-7. PubMed ID: 15756445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational analysis of tumour suppressor gene NF2 in common solid cancers and acute leukaemias.
    Yoo NJ; Park SW; Lee SH
    Pathology; 2012 Jan; 44(1):29-32. PubMed ID: 22081132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BCL10 is rarely mutated in human prostate carcinoma, small-cell lung cancer, head and neck tumours, renal carcinoma and sarcomas. MPT Collaborators, St George's Hospital Collaborators.
    Gill S; Broni J; Jefferies S; Osin P; Kovacs G; Maitland NJ; Eeles R; Edwards SM; Dyer MJ; Willis TG; Cooper CS
    Br J Cancer; 1999 Jul; 80(10):1565-8. PubMed ID: 10408398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational analysis of PTPRT phosphatase domains in common human cancers.
    Lee JW; Jeong EG; Lee SH; Nam SW; Kim SH; Lee JY; Yoo NJ; Lee SH
    APMIS; 2007 Jan; 115(1):47-51. PubMed ID: 17223850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatic mutations of the KEAP1 gene in common solid cancers.
    Yoo NJ; Kim HR; Kim YR; An CH; Lee SH
    Histopathology; 2012 May; 60(6):943-52. PubMed ID: 22348534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 gene alteration in atypical epithelial lesions and carcinoma in patients with idiopathic pulmonary fibrosis.
    Kawasaki H; Ogura T; Yokose T; Nagai K; Nishiwaki Y; Esumi H
    Hum Pathol; 2001 Oct; 32(10):1043-9. PubMed ID: 11679937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 gene mutations in human epithelial skin cancers.
    Molès JP; Moyret C; Guillot B; Jeanteur P; Guilhou JJ; Theillet C; Basset-Sèguin N
    Oncogene; 1993 Mar; 8(3):583-8. PubMed ID: 8437842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.